2025-11-15T07:04:27-05:00 2024-12-31 ERNST & YOUNG US LLP 99 WOOD AVENUE SOUTH ISELIN NJ 08830 990 2024-01-01 832048489 Hypopara Research Foundation % JAMES H GREENE III HYPO 6502452596 155 BOVET RD STE 770 San Mateo CA 94402 JAMES GREENE PRESIDENT 6506532406 2025-11-14 true true MICHAEL R SALES P01770943 7325164200 2025-11-14 2024 2025-03-06 01:10:19Z JAMES GREENE 155 BOVET ROAD SUITE 770 San Mateo CA 94402 3000 false X N/A X 2018 CA HRF'S MISSION IS TO FUND INNOVATIVE, COLLABORATIVE RESEARCH WITH THE NARROW AIM OF IMPROVING THE QUALITY OF LIFE FOR THOSE SUFFERING FROM AND ULTIMATELY CURING HYPOPARATHYROIDISM 1 1 0 3 0 0 210 3000 0 0 0 0 0 0 210 3000 0 91765 0 0 0 0 0 0 0 3850 7725 3850 99490 -3640 -96490 162580 66090 0 0 162580 66090 X HRF'S MISSION IS TO FUND INNOVATIVE, COLLABORATIVE RESEARCH WITH THE NARROW AIM OF IMPROVING THE QUALITY OF LIFE FOR THOSE SUFFERING WITH HYPOPARATHYROIDISM AND ULTIMATELY CURING HYPOPARATHYROIDISM. false false 91765 91765 0 HYPOPARA RESEARCH FOUNDATION MADE PROGRAMMATIC GRANT DISBURSEMENTS DURING 2024 IN THE AMOUNT OF $91,765 IN SUPPORT OF THE DEVELOPMENT OF TRANSFORMATIVE THERAPIES THAT CAN BE DEPLOYED ACROSS MULTIPLE RARE DISEASES. THE GRANT FUNDS SUPPORT A PLAN TO DEVELOP A ROADMAP FOR PARATHYROID CELL DIFFERENTIATION, SUPPORT THE DEVELOPMENT HUMAN PARATHYROID CELLS USING SINGLE CELL TRANSCRIPTOMICS AND MACHINE LEARNING ALGORITHMS, AND SUPPORT THE DEVELOPMENT OF AN IN-HOME IONIZED CALCIUM MONITORING DEVICE. 91765 true false false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false false true 0 0 0 false false false false false false false false false false false false X 1 1 false false false false false true true false false false false false true true true false false false false false CA X JAMES H GREENE III 6506532406 155 BOVET ROAD SUITE 770 SAN MATEO CA 94402 X JAMES H GREENE III PRESIDENT, BOARD MEMBER 1.0 0.0 X X 0 0 0 0 0 0 0 false false false 0 3000 3000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3000 91765 91765 0 0 0 0 0 0 0 0 0 0 0 7700 7700 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 REGISTRATION FEES 25 25 99490 91765 7725 0 162580 66090 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 162580 66090 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 0 162580 66090 162580 66090 162580 66090 -96490 X false false false X 276265 46390 67732 210 3000 393597 0 0 276265 46390 67732 210 3000 393597 174503 219094 0 0 0 393597 0.55665 0.74459 X true UNIVERSITY OF PENNSYLVANIA 3451 Walnut Street Suite 305 Philadelphia PA 19104 231352685 501(c)(3) 91765 Hypoparathyroidism Orphan Disease 1 0 SCHEDULE I, PART I, LINE 2 The University of Pennsylvania Orphan Disease Center (Center) acts as an outsourced scientific medical board for the foundation. The Foundation advises as to what research the Center will fund, and the Center creates a request for proposal and distributes funds to selected researchers. The Center inquires as to the use of the funds by researchers and the Center reports back to the Foundation to ensure that the funds are being used in a manner that is consistent with the terms and purpose of the grant. SCHEDULE O FORM 990, PART VI, LINE 7A The President of Hypopara Research Foundation has the authority to designate members of the governing body. FORM 990, PART VI, LINE 7B The President of Hypopara Research Foundation has the authority TO approve decisions of the governing body. FORM 990, PART VI, LINES 8A AND 8B The Foundation does not currently document meetings held or actions undertaken during the year by the governing body and those authorized to act on behalf of the governing body. In the future, the foundation will develop a process to document meetings on at least an annual basis. FORM 990, PART VI, LINE 11B - FORM 990 REVIEW PROCESS THE FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM. THE FORM 990 IS THEN REVIEWED BY THE PRESIDENT OF HYPOPARA RESEARCH FOUNDATION PRIOR TO BEING FILED WITH THE IRS. Form 990, Part VI, Line 12C THE FOUNDATION REQUIRES EACH BOARD MEMBER, OFFICER, AND OTHER INTERESTED PERSONS, TO PROMPTLY DISCLOSE ANY POTENTIAL CONFLICT TO THE BOARD OF DIRECTORS, UPON LEARNING OF A PROPOSED TRANSACTION. THE BOARD ANALYZES THE POTENTIAL TRANSACTION AND DETERMINES WHETHER A CONFLICT EXISTS. IF A CONFLICT EXISTS, AND THE REMAINING BOARD MEMBERS SHALL DECIDE THE MATTER. THE FOUNDATION REQUIRES EACH BOARD MEMBER AND OFFICER TO SIGN AN ANNUAL STATEMENT THAT AFFIRMS THAT THEY HAVE RECEIVED AND READ THE CONFLICT OF INTEREST POLICY, AND TO DISCLOSE ANY FINANCIAL INTERESTS AND RELATIONSHIPS THAT COULD GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, LINE 19 The Foundation does not currently have a formal process to make governing documents, conflict of interest policy, and financial statements available to the public. Any such request would be deferred to the Foundation's attorney.